News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,882 Results
Type
Article (39699)
Company Profile (247)
Press Release (658936)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204169)
Career Advice (2007)
Deals (35418)
Drug Delivery (95)
Drug Development (81045)
Employer Resources (172)
FDA (16182)
Job Trends (14858)
News (345189)
Policy (32539)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49433)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (125)
Approvals (16186)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2260)
Cardiovascular disease (175)
Career advice (1676)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (19)
Clinical research (65988)
Collaboration (833)
Company closure (1)
Compensation (547)
Complete response letters (19)
COVID-19 (2589)
CRISPR (40)
C-suite (242)
Cystic fibrosis (100)
Data (2211)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (271)
Diagnostics (6370)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86643)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112414)
Executive appointments (722)
FDA (17447)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (748)
Gene editing (105)
Generative AI (19)
Gene therapy (302)
GLP-1 (709)
Government (4417)
Grass and pollen (4)
Guidances (68)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2731)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16508)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (468)
Leadership (17)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (68)
Medical device (13378)
Medtech (13383)
Mergers & acquisitions (19455)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1913)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (364)
Opinion (204)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57302)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20559)
Phase II (29057)
Phase III (21649)
Pipeline (1208)
Policy (139)
Postmarket research (2563)
Preclinical (8738)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22285)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (690)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (37)
Last 7 days (851)
Last 30 days (2500)
Last 365 days (32638)
2025 (10773)
2024 (35219)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37840)
Australia (6184)
California (6143)
Canada (2020)
China (524)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81258)
Florida (912)
Georgia (206)
Idaho (57)
Illinois (536)
India (25)
Indiana (308)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4575)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1727)
New Mexico (28)
New York (1750)
North Carolina (967)
North Dakota (8)
Northern California (2687)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (23)
South Dakota (1)
Southern California (2308)
Tennessee (101)
Texas (909)
United States (23154)
Utah (182)
Virginia (146)
Washington D.C. (62)
Washington State (552)
West Virginia (3)
Wisconsin (54)
698,882 Results for "verastem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verastem Oncology to Present at Upcoming Investor Conferences
May 1, 2025
·
1 min read
Press Releases
Verastem Oncology Announces $75 million Private Placement
April 28, 2025
·
4 min read
Press Releases
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 7, 2025
April 8, 2025
·
1 min read
Press Releases
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025
March 25, 2025
·
11 min read
Press Releases
Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
March 20, 2025
·
20 min read
Press Releases
Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference
January 29, 2025
·
1 min read
Press Releases
Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
April 23, 2025
·
7 min read
Press Releases
Verastem Oncology Names Matthew E. Ros as Chief Operating Officer
January 15, 2025
·
3 min read
Press Releases
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
February 21, 2025
·
8 min read
Deals
Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes
Verastem Oncology today announced that in connection with the 2024 Russell U.S. Indexes annual reconstitution, the company will be added to the Russell 3000 ® and Russell Microcap ® Indexes, effective at the open of U.S. equity markets today, Monday, July 1, 2024.
July 1, 2024
·
9 min read
1 of 69,889
Next
